SEPTInvestingStart Free

ABUS SCHEDULE 13G/A: SEC filing

Arbutus Biopharma Corp

Filed with the SEC on · accession 0002012383-26-003716

ABUS filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Oct 27, 2026. Arbutus Biopharma Corp filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The stock moved +2.1% by the first close after the filing.

Summary of the filing

Arbutus Biopharma Corp filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The filing indicates a change in the ownership position of a reporting holder, though specific details are not disclosed in the provided text.

For details, click here →

Key details

IssuerArbutus Biopharma Corp

How ABUS stock reacted

Close before

$4.20

Oct 26, 2026

First close after

+2.14%

$4.29

5 trading days

-4.76%

$4.00

Since filing

-3.33%

$4.06

✦ Ask GOAX AI about this filing — what it means for ABUS, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for ABUS?

Click here

Frequently asked questions

What did ABUS file with the SEC on Oct 27, 2026?

ABUS filed a SCHEDULE 13G/A (SEC filing). Arbutus Biopharma Corp filed a Schedule 13G/A, an amendment to a previously filed passive ownership statement. The filing indicates a change in the ownership position of a reporting holder, though specific details are not disclosed in the provided text.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did ABUS stock react to this filing?

ABUS closed at $4.20 before the filing and $4.29 on Oct 27, 2026 (+2.14%). Five trading days later: $4.00 (-4.76%).

Other ABUS SEC filings

Get alerts when ABUS files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
ABUS overviewABUS analysisABUS newsLatest SEC filings